离岸价格
获取最新报价( Negotiable )
|Minimum Order
位置:
china
最小订单价格:
-
最小订单:
100 Gram
包装细节:
Aluminum foil bag, PTFE Bottle, or meet your requirment
交货时间:
Within one week
供应能力:
10 Kilogram per Month
付款方式:
T/T, L/C, D/P
联系人 Mr. James
Building A, NO.688,Qiushi Road,Jinshan District, Shanghai, shanghai
| Axitinib is an investigational drug being developed by Pfizer for treating advanced renal cell carcinoma (ARCC) and hepatocellular carcinoma.The drug is being investigated as a single dose therapy, as well as in combination with chemotherapy.Pfizer submitted a new drug application for the treatment of advanced renal cell carcinoma based on the Phase III AXIS ***2 trial.The drug has been approved for review by the FDA in June ***1.The drug was also accepted for review by the European Medicines Agency in June ***1.The review will be based on the Phase III AXIS ***2 trial.More than **0,**0 people are diagnosed with renal cell carcinoma every year and **2,**0 people die as a result of the cancer. |
